Jie Zhang – InmunoES

Survival benefit and immune-related toxicities after hematopoietic stem cell transplantation in Krabbe disease: a systematic review and meta-analysis

13 de August de 2026 by Jie Zhang

BackgroundKrabbe disease is a rare, rapidly progressive leukodystrophy with high early mortality. Hematopoietic stem cell transplantation (HSCT) is the main disease-modifying intervention used in clinical practice and may act through donor-derived myel…

Targeting KIF20A: a new frontier in cancer treatment revealed by multi-omics analysis

21 de January de 2026 by Jie Zhang

BackgroundKinesin family member 20A (KIF20A), a microtubule-dependent motor protein of the Kinesin superfamily, is involved in cell division and organelle transport. Its expression is dysregulated in various cancers and is closely related to tumor meta…

Dual immunotherapy alternating with anti-PD-1 antibody plus liposomal doxorubicin show good efficacy in prostate epithelioid hemangioendothelioma: a case report

14 de June de 2024 by Jie Zhang

Epithelioid hemangioendothelioma is a rare vascular malignancy, and currently, there is no standard treatment regimen for this disease and existing treatment options have limited efficacy. In this case report, we present a patient with lung and lymph n…